Cancer Answers: Young Adult Oncology
July 25, 2019Information
Young Adult Oncology with guest Dr. Asher Marks, March 17, 2019
ID4340
To CiteDCA Citation Guide
- 00:00Support for Yale Cancer Center Answers comes from AstraZeneca, working to eliminate cancer as a cause of death. Learn more at astrazeneca-us.com 00:08.400 --> 00:54.200 Welcome to Yale Cancer Answers with doctors Anees Chapgar and Steven Gore. I am Bruce Barber. Yale Cancer Answers features the latest information on cancer care by welcoming oncologists and specialists who are on the forefront of the battle to fight cancer. This week, it is a conversation about young adult oncology with Dr. Asher Marks and Amanda Garbatini. Dr. Marks is an Assistant Professor of Pediatrics in Hematology and Oncology at the Yale School of Medicine and Ms. Garbatini is the Adolescent Young Adult Program Coordinator at Yale New Haven Hospitals. Dr. Gore is a Professor of Internal Medicine and Hematology at Yale and Director of Hematologic Malignancies at Smilow Cancer Hospital.
- 13:53Medical Minute Support for Yale Cancer Answers comes from AstraZeneca, a lobal science-led biopharmaceutical business committed to bringing to market innovative oncology medicines that address unmet needs for people living with cancer. More at astrazeneca-us.com. 14:08.700 --> 14:52.000 This is a medical minute about melanoma. While melanoma accounts for only about 4% of skin cancer cases, it causes the most skin cancer deaths. When detected early, however, melanoma is easily treated and highly curable. Clinical trials are currently under way to test innovative new treatments for melanoma. The goal of the specialized programs of research excellence in skin cancer or SPORE Grant is to better understand the biology of skin cancer with a focus on discovering targets that will lead to improved diagnosis and treatment. More information is available at YaleCancerCenter.org. You are listening to Connecticut Public Radio. 14:52.000 --> 15:30.400